Seegene Germany GmbH

Seegene Germany GmbH, based in Düsseldorf, is the German subsidiary of Seegene Inc., a leader in molecular diagnostics. Established in September 2017, the company specializes in developing, approving, and marketing innovative in vitro diagnostic (IVD) solutions in Germany, particularly using multiplex real-time PCR technologies. The company’s core technologies include patented platforms like Dual Priming Oligonucleotide (DPO™) and Tagging Oligonucleotide Cleavage and Extension (TOCE™), allowing for the simultaneous detection of multiple pathogens in a single test. Seegene Germany offers a range of diagnostic solutions, including multiplex assays for infectious diseases, DNA extraction, automated PCR analysis, and intelligent data evaluation. Their products are designed for high sensitivity and specificity, supporting early diagnosis and personalized patient care. Seegene Germany serves diagnostic laboratories, hospitals, clinics, and research institutions, providing advanced tools for infection detection and management. The company is committed to improving laboratory efficiency and diagnostic reliability through continuous investment in research and technology.

• Employees37
• Founded2017